TP53 and endometrial cancer: Bonazzi et al. performed WES on endometrial cancers with four common molecular subtypes: those with DNA polymerase epsilon (POLE) mutations, mismatch repair deficiency (MMRd), p53 mutations, and without any specific molecular profile.